Partnering Opportunities In China

Tasly in China is one of China’s largest publicly listed pharmaceutical companies (Shanghai: SHSE:600535), with over 19,000 employees and more than 40 subsidiaries globally. In China, we have one of the most significant sales forces and teams with China FDA compliant clinical and regulatory capabilities. Besides license-in drugs into China, we provide comprehensive services in

  • Regulatory submission/registration.
  • Research and development consultation.
  • Other related areas.

Our business development contact: